BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8821051)

  • 1. Iron-dependent enzymes in Parkinson's disease.
    Reichmann H; Janetzky B; Riederer P
    J Neural Transm Suppl; 1995; 46():157-64. PubMed ID: 8821051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.
    Hattori N; Tanaka M; Ozawa T; Mizuno Y
    Ann Neurol; 1991 Oct; 30(4):563-71. PubMed ID: 1665052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal.
    Schapira AH
    Mov Disord; 1994 Mar; 9(2):125-38. PubMed ID: 8196673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA analysis in Parkinson's disease.
    Schapira AH; Holt IJ; Sweeney M; Harding AE; Jenner P; Marsden CD
    Mov Disord; 1990; 5(4):294-7. PubMed ID: 1979656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origin and functional consequences of the complex I defect in Parkinson's disease.
    Swerdlow RH; Parks JK; Miller SW; Tuttle JB; Trimmer PA; Sheehan JP; Bennett JP; Davis RE; Parker WD
    Ann Neurol; 1996 Oct; 40(4):663-71. PubMed ID: 8871587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities of the electron transport chain in idiopathic Parkinson's disease.
    Parker WD; Boyson SJ; Parks JK
    Ann Neurol; 1989 Dec; 26(6):719-23. PubMed ID: 2557792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex I, iron, and ferritin in Parkinson's disease substantia nigra.
    Mann VM; Cooper JM; Daniel SE; Srai K; Jenner P; Marsden CD; Schapira AH
    Ann Neurol; 1994 Dec; 36(6):876-81. PubMed ID: 7998774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain.
    Cooper JM; Daniel SE; Marsden CD; Schapira AH
    Mov Disord; 1995 May; 10(3):295-7. PubMed ID: 7651446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of the mitochondrial A7237T mutation in Parkinson's disease.
    Lücking CB; Kösel S; Mehraein P; Graeber MB
    Biochem Biophys Res Commun; 1995 Jun; 211(2):700-4. PubMed ID: 7794285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group.
    Schapira AH; Mann VM; Cooper JM; Krige D; Jenner PJ; Marsden CD
    Ann Neurol; 1992; 32 Suppl():S116-24. PubMed ID: 1510369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex I and Parkinson's disease.
    Greenamyre JT; Sherer TB; Betarbet R; Panov AV
    IUBMB Life; 2001; 52(3-5):135-41. PubMed ID: 11798025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What process causes nigral cell death in Parkinson's disease?
    Jenner P
    Neurol Clin; 1992 May; 10(2):387-403. PubMed ID: 1584181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and animal studies of Parkinson's disease.
    Oertel WH; Kupsch A
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra.
    van Muiswinkel FL; de Vos RA; Bol JG; Andringa G; Jansen Steur EN; Ross D; Siegel D; Drukarch B
    Neurobiol Aging; 2004 Oct; 25(9):1253-62. PubMed ID: 15312971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson disease: primacy of age as a risk factor for mitochondrial dysfunction.
    Vanitallie TB
    Metabolism; 2008 Oct; 57 Suppl 2():S50-5. PubMed ID: 18803967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detrimental deletions: mitochondria, aging and Parkinson's disease.
    Biskup S; Moore DJ
    Bioessays; 2006 Oct; 28(10):963-7. PubMed ID: 16998822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of iron in Parkinson disease and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Yantiri F; Andersen JK
    IUBMB Life; 1999 Aug; 48(2):139-41. PubMed ID: 10794588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease.
    Mizuno Y; Matuda S; Yoshino H; Mori H; Hattori N; Ikebe S
    Ann Neurol; 1994 Feb; 35(2):204-10. PubMed ID: 8109900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.
    Hattori N; Ikebe S; Tanaka M; Ozawa T; Mizuno Y
    Adv Neurol; 1993; 60():292-6. PubMed ID: 8380521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.